• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

27/01/2026 12:37

Alembic Pharmaceutic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%.